lystn

How close are we to targeted treatments designed to each person with eczema? As parents, we often hear from people about a miracle approach that “cured” their or their child’s eczema, only to find that this same approach doesn’t work for us. We are continually reminded of the many different ways that eczema can appear and feel, and how people respond differently to different treatments. Right now, we have a largely “trial and error” approach to treating eczema but what will the future look like as we begin to understand eczema variation, subtypes, and personalized medicine? In this episode of the Eczema Breakthroughs podcast we chat with Professor Thomas Bieber who is chair and director of the department of dermatology and allergy at the University of Bonn in Germany. His cutting edge research focuses on biomarker discovery and precision medicine in allergic skin diseases, and he was a speaker on the topic of risk stratification at the recent http://www.revolutionizingad.com/ (Revolutionizing Atopic Dermatitis global conference) in April.   Research referenced in this episode: https://www.jacionline.org/article/S0091-6749(17)30148-3/fulltext (Eczema types: Where are we and where should we go? ) Support this podcast